Results of a first-in-class clinical trial on ibogaine-magnesium therapy for Special Operations Veterans (SOV) with repeated blast exposure have been published in the journal Nature. Although preliminary, outcomes have long been awaited as they provide evidence of ibogaine’s neuro-restorative effects.